Glycos Biotechnologies enters definitive agreement with Malaysian Bio-XCell for biochemical plant and R&D facility; focus on isoprene
November 1st, 2010
Glycos Biotechnologies, Inc., an emerging biochemical company applying metabolic engineering and microbiology innovations for the production of sustainable biochemicals, exchanged definitive agreements with Malaysian Bio-XCell for the establishment of an industrial biochemical plant and biotechnology R&D facility in Malaysia.
